Entrada Therapeutics | DEFA14A: Others
Apr 29 09:18 ET
Entrada Therapeutics | DEF 14A: Definitive information statements
Apr 29 09:13 ET
Entrada Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Apr 19 07:03 ET
Entrada Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Mar 13 07:38 ET
Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Mar 13 07:13 ET
Entrada Therapeutics | 8-K: Current report
Jan 3 00:00 ET
Entrada Therapeutics | 8-K: Current report
Dec 6, 2023 07:00 ET
Entrada Therapeutics | 8-K: Current report
Nov 22, 2023 07:35 ET
Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Third Quarter 2023 Financial Results
Nov 7, 2023 07:08 ET
Entrada Therapeutics | 8-K: Current report
Nov 1, 2023 07:01 ET
Entrada Therapeutics | 8-K: Current report
Sep 29, 2023 16:39 ET
Entrada Therapeutics | 8-K: Current report
Sep 21, 2023 07:09 ET
Entrada Therapeutics | 8-K: Current report
Aug 10, 2023 07:09 ET
Entrada Therapeutics | 8-K: Entrada Therapeutics Reports Second Quarter 2023 Financial Results
Aug 8, 2023 07:07 ET
Entrada Therapeutics | 8-K: Current report
Aug 1, 2023 07:08 ET
Entrada Therapeutics | 8-K: Current report
Jun 8, 2023 17:11 ET
Entrada Therapeutics | 8-K: Entrada Therapeutics Reports First Quarter 2023 Financial Results
May 10, 2023 07:16 ET
Entrada Therapeutics | DEFA14A: Others
Apr 25, 2023 07:01 ET
Entrada Therapeutics | DEF 14A: Definitive proxy statements
Apr 25, 2023 07:00 ET
Entrada Therapeutics | 8-K: Current report
Apr 4, 2023 07:16 ET
No Data
No Data